Real-world Efficacy of Erenumab on Migraine-associated Symptoms and Patient-reported Satisfaction Levels: A Retrospective Study in Japan
Keiko Ihara(Keio University), Tsubasa Takizawa(Keio University), Kei Ishizuchi(Keio University Hospital), Nobuyuki Takahashi(Keio University Hospital), Jin Nakahara(Keio University Hospital), Daiki Tokuyasu(Keio University), Shungo Imai(Keio University), Naoki Miyazaki(Keio University Hospital), Narumi Watanabe(Keio University Hospital), Satoko Hori(Keio University), Ryo Takemura(Keio University Hospital), Seiya Ohtani(Keio University), Koji Sekiguchi(Keio University Hospital)
Cited by 6
Related Papers
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|174
Spreading depolarizations trigger caveolin‐1–dependent endothelial transcytosis
|Annals of Neurology|2018|107
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
|Cephalalgia|2024|107
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
|Cephalalgia|2024|106
Spreading depression as a preclinical model of migraine
|The Journal of Headache and Pain|2019|104